Dimberg, Anna
Rudbecklaboratoriet,
Sweden
2024 Rank: 94,604
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Immunology
Rank in SubField 1: 3,119 out of 334,837 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 94,604 | 104,807 |
| Total Cites | 915 | 959 |
| H-index | 12 | 12 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 3 | 3 |
| Total Cites to Single Authored Papers | 8 | 9 |
| Number of Single+First Authored Papers | 11 | 11 |
| Total Cites to Single+First Authored Papers | 24 | 25 |
| Number of Single+First+Last Authored Papers | 33 | 33 |
| Total Cites to Single+First+Last Authored Papers | 465 | 477 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 834 | 851 |
| Ratio of Total Citations to Distinct Citing Papers | 1.10 | 1.13 |
| Self-Citation Percentage |
4.59%
|
|
Dimberg, Anna
Rudbecklaboratoriet,
Sweden
2023 Rank: 107,304
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Immunology
Rank in SubField 1: 3,820 out of 312,644 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 107,304 | 110,361 |
| Total Cites | 848 | 889 |
| H-index | 11 | 12 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 3 | 3 |
| Total Cites to Single Authored Papers | 9 | 10 |
| Number of Single+First Authored Papers | 11 | 11 |
| Total Cites to Single+First Authored Papers | 21 | 22 |
| Number of Single+First+Last Authored Papers | 30 | 30 |
| Total Cites to Single+First+Last Authored Papers | 417 | 425 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 775 | 804 |
| Ratio of Total Citations to Distinct Citing Papers | 1.09 | 1.11 |
| Self-Citation Percentage |
4.61%
|
|
Dimberg, Anna
Rudbecklaboratoriet,
Sweden
2022 Rank: 81,327
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Immunology
Rank in SubField 1: 3,088 out of 293,195 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 81,327 | 102,146 |
| Total Cites | 749 | 809 |
| H-index | 12 | 12 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 3 | 3 |
| Total Cites to Single Authored Papers | 14 | 14 |
| Number of Single+First Authored Papers | 11 | 11 |
| Total Cites to Single+First Authored Papers | 31 | 31 |
| Number of Single+First+Last Authored Papers | 29 | 29 |
| Total Cites to Single+First+Last Authored Papers | 318 | 337 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 697 | 732 |
| Ratio of Total Citations to Distinct Citing Papers | 1.07 | 1.11 |
| Self-Citation Percentage |
7.42%
|
|
Dimberg, Anna
University of Uppsala Rudbeck Laboratory,
Sweden
2021 Rank: 97,147
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Immunology
Rank in SubField 1: 3,471 out of 271,773 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 97,147 | 106,433 |
| Total Cites | 944 | 1,021 |
| H-index | 14 | 15 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 3 | 3 |
| Total Cites to Single Authored Papers | 20 | 20 |
| Number of Single+First Authored Papers | 11 | 11 |
| Total Cites to Single+First Authored Papers | 40 | 40 |
| Number of Single+First+Last Authored Papers | 27 | 27 |
| Total Cites to Single+First+Last Authored Papers | 328 | 349 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 879 | 930 |
| Ratio of Total Citations to Distinct Citing Papers | 1.07 | 1.10 |
| Self-Citation Percentage |
7.54%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.